Ocuphire Pharma Stock Story
| OCUP Stock | USD 1.83 0.11 5.67% |
Slightly above 64% of all Ocuphire Pharma's retail investors are looking to take a long position. The analysis of the overall investor sentiment regarding Ocuphire Pharma suggests that some traders are interested. Ocuphire Pharma's investor sentiment overview provides quick insight into current market opportunities from investing in Ocuphire Pharma. The current market sentiment, together with Ocuphire Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Ocuphire Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Ocuphire Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ocuphire daily returns and investor perception about the current price of Ocuphire Pharma as well as its diversification or hedging effects on your existing portfolios.
Ocuphire |
Requested story not found. it has been either deleted or moved. View all stories for Ocuphire Pharma.
Ocuphire Pharma Latest Timeline
Ocuphire Pharma is listed for 1.83. About 14.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.91. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ocuphire Pharma recorded a loss per share of 0.46. The entity last dividend was issued on the 6th of November 2020. The firm had 1:4 split on the 6th of November 2020.Check out Ocuphire Pharma Hype Analysis, Ocuphire Pharma Correlation and Ocuphire Pharma Performance. To learn how to invest in Ocuphire Stock, please use our How to Invest in Ocuphire Pharma guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Ocuphire Stock analysis
When running Ocuphire Pharma's price analysis, check to measure Ocuphire Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocuphire Pharma is operating at the current time. Most of Ocuphire Pharma's value examination focuses on studying past and present price action to predict the probability of Ocuphire Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocuphire Pharma's price. Additionally, you may evaluate how the addition of Ocuphire Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Ocuphire Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocuphire Pharma. If investors know Ocuphire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocuphire Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.882 | Quarterly Revenue Growth (0.96) | Return On Assets (0.13) | Return On Equity (0.21) |
The market value of Ocuphire Pharma is measured differently than its book value, which is the value of Ocuphire that is recorded on the company's balance sheet. Investors also form their own opinion of Ocuphire Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ocuphire Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocuphire Pharma's market value can be influenced by many factors that don't directly affect Ocuphire Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocuphire Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocuphire Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocuphire Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.